• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Acadia Pharmaceuticals

FDA
Pharma

FDA approves Soleno's Vykat XR for insatiable hunger disorder

The FDA has approved Soleno Therapeutics' Vykat XR as the first treatment for insatiable hunger related to the rare condition Prader-Willi Syndrome.
Kevin Dunleavy Mar 27, 2025 11:24am
Catherine Owen Adams

JPM25: Acadia’s new CEO sets sights on company's first $1B year

Jan 17, 2025 1:22pm
graphic of the brain and the electrical signals that make it up

Acadia nabs Lexicon alum as new commercial lead

Dec 9, 2024 9:26am
Acadia Pharmaceuticals Ryan Reynolds More to Parkinsons campaign

Acadia joins forces with Ryan Reynolds for Parkinson’s awareness

Aug 14, 2024 11:43am
Acadia Pharmaceuticals Rett syndrome docuseries

Acadia adds awareness-raising docuseries to Rett syndrome site

May 15, 2024 1:02pm
Graphic showing arrows missing the bullseye on a target

Acadia gives up on future Nuplazid studies after latest flop

Mar 12, 2024 11:58am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings